selected publications

• article

  • Ancillary subunits KChIP2c and DPP6 differentially modulate the inhibition of Kv4.2 channels by riluzole.  European Journal of Pharmacology.  986:-. 2025-01-01
  • Differential voltage-dependent modulation of the ACh-gated K current by adenosine and acetylcholine.  PLoS ONE.  17:-. 2022-01-01
  • Serum zinc levels are associated with obesity and low-density lipoprotein cholesterol in Mexican adults.  Journal of Trace Elements in Medicine and Biology.  73:-. 2022-01-01
  • Kir4.1/kir5.1 channels possess strong intrinsic inward rectification determined by a voltage-dependent k -flux gating mechanism.  Journal of General Physiology.  153:-. 2021-01-01
    
  • Voltage-induced structural modifications on M2 muscarinic receptor and their functional implications when interacting with the superagonist iperoxo.  Biochemical Pharmacology.  177:-. 2020-01-01
  Chloroquine blocks the Kir4.1 channels by an open-pore blocking mechanism.  European Journal of Pharmacology.  800:40-47. 2017-01-01
  
  Inhibition of Kir4.1 potassium channels by quinacrine.  Brain Research.  1663:87-94. 2017-01-01
  Impact of the whole-cell patch-clamp configuration on the pharmacological assessment of the hERG channel: Trazodone as a case example.  Journal of Pharmacological and Toxicological Methods.  69:237-244. 2014-01-01
  Kv1.5 open channel block by the antiarrhythmic drug disopyramide: Molecular determinants of block.  Journal of Pharmacological Sciences.  108:49-55. 2008-01-01
  The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel.  Proceedings of the National Academy of Sciences of the United States of America.  105:1364-1368. 2008-01-01
  Block of hERG channels by berberine: Mechanisms of voltage- and state-dependence probed with site-directed mutant channels.  Journal of Cardiovascular Pharmacology.  47:21-29. 2006-01-01
  Inhibition of cardiac HERG potassium channels by antidepressant maprotiline.  European Journal of Pharmacology.  531:1-8. 2006-01-01
  The D3-dopaminergic agonist 7-hydroxy-dipropylaminotetralin (7-OH-DPAT) increases cardiac action potential duration and blocks human ether-a-go-go-related gene K channel.  Journal of Cardiovascular Pharmacology.  47:656-662. 2006-01-01
  ... more